Why executive health screening needs a check-up
Originally published on HR Magazine
Executive health screens are a common benefit, but does the evidence behind such a perk stack up?
The ritual of the annual executive health screen is well-entrenched. Estimates suggest that private health assessments cost UK industry more than £65 million annually. Is this money well spent, or should the perk carry its own health warning?
At first glance an annual health check is a sensible, progressive and responsible service for organisations to provide. It ensures employee wellbeing, provides opportunity for early diagnosis of undetected illness, and peace of mind to executives with plenty of other things to worry about. So what’s not to like?
Medical scepticism about the efficacy of health checks has long existed. The Academy of Medical Royal Colleges and the British Medical Association have independently voiced concerns that some tests performed demonstrate little or no evidence of patient benefit. Private executive medical examinations incorporate tests that may not be recommended in an otherwise well population and may be ineffective at picking up real disease.
More is certainly not better – the more screening tests on offer the greater the cumulative likelihood of a false result requiring needless investigation. So far from being a benefit, in a substantial minority of cases they actually lead to harm.
Over-investigation is not the only problem. The insidious effect of false reassurance also comes into play. Already busy executives may be tempted to devolve responsibility for their health, assuming that they can defer reporting new symptoms in favour of awaiting the next annual health check, or being over-reliant on the seemingley favourable set of results from the last. Sadly, despite the gold-plated service, the plush comfort of the clinics, and the apparently scientific reports produced, executives are not receiving a service with an evidence base to commend it.
Bad for your wealth
Annual checks are not cost-effective. Consumer publication Which? concluded that private health screening represents poor value for money, and a recent paper in the New England Journal of Medicine judged that executive medicals fail on three counts; efficacy, cost and equity. There is no direct evidence of any correlation between investment in health checks and the health or performance of the employee or executive.
It is therefore surprising that HRDs have been slow to challenge in this area. Perhaps the corporate health check is “part of the package” for many executives, and its withdrawal would send the wrong message. But to carry on investing significant sums in an intervention that lacks evidence because you can’t imagine an alternative option is a lazy solution.
Time for a different medicine?
Company health interventions should ideally meet two criteria; improvement of colleague health and increasing in-role performance. Wellness is less about the absence of sickness, and more about the ability to perform with an agile body and mind. Organisations need to find ways to enhance employees’ ability to manage their ongoing health and performance.
Redirecting investment towards the provision of relevant and effective advice that drives real health and performance benefit. This could be direct-to-business delivery of practical tools to maximise daily health awareness and improvement. Such interventions equip executives to take informed responsibility for their ongoing health and performance.
Addressing organisational culture and heath concurrently to enable executives to maximise individual health, energy and performance. More enlightened management teams are actively managing work patterns and support mechanisms.
Targeted one-to-one or small group programmes that create specific goals, track changes, and provide ongoing support and feedback.
Companies prepared to make investments in employee health and wellbeing deserve applause. They have the potential to both improve productivity in the workplace and create healthier and happier individuals. Sadly the annual corporate medical isn’t making a meaningful contribution, so it’s time to change the prescription.
Sarah Hattam is a GP from West Yorkshire who has an interest in the application of health to improve performance in the workplace